Intimation about closure of trading window for Q ended 30th september 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Sandu Pharmaceuticals has informed the stock exchange that its trading window will remain closed from Wednesday, 1st October 2025 until 48 hours after the announcement of unaudited financial results for the quarter ended 30th September 2025. This is a standard compliance measure under the SEBI (Prohibition of Insider Trading) Regulations, 2015, aimed at preventing insider trading ahead of results announcement. The restriction applies to Directors, Key Managerial Personnel (KMPs), Promoters, Promoters Group, Designated Persons, and their immediate relatives. The date of the board meeting to consider the financial results will be communicated separately.
This is a routine regulatory filing with no material impact on the stock or shareholders. Investors should note that the company's Q2 FY26 results are upcoming, and the trading window closure signals that results will be announced within the next few weeks, which could be a catalyst for price movement depending on the numbers.